Schmidt Mikayla A, Marcano-Bonilla Lorena, Roberts Lewis R
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; University of Puerto Rico School of Medicine, San Juan, PR, USA.
Chin Clin Oncol. 2019 Aug;8(4):31. doi: 10.21037/cco.2019.08.13.
Gallbladder cancer (GBC) is a form of hepatobiliary malignancy that develops from the mucosal lining of the gallbladder. The early development of gallbladder cancer is usually asymptomatic and gallbladder cancer has a high propensity to metastatic dissemination, thus most patients are diagnosed at intermediate to advanced stages for which there is no curative treatment. Consequently, gallbladder cancer is highly lethal. Though the overall global incidence of gallbladder cancer is low, there is marked geographic variation and ethnic communities in Asia as well as Native American populations in both North and South America are affected disproportionately. This article provides a comprehensive overview of the current epidemiology and risk and protective factors associated with gallbladder cancer development. In addition, the current knowledge on environmental and genetic risk associations for gallbladder cancer and the need for additional large-scale genome wide association studies (GWAS) are discussed.
胆囊癌(GBC)是一种发生于胆囊黏膜的肝胆恶性肿瘤。胆囊癌早期通常没有症状,且极易发生转移扩散,因此大多数患者在疾病发展至中晚期时才被确诊,而此时已无治愈性治疗方法。所以,胆囊癌的致死率很高。尽管全球胆囊癌的总体发病率较低,但存在显著的地理差异,亚洲的一些种族群体以及南北美洲的美洲原住民人口受其影响尤为严重。本文全面概述了当前胆囊癌的流行病学以及与胆囊癌发生相关的风险和保护因素。此外,还讨论了目前关于胆囊癌环境和遗传风险关联的知识,以及开展更多大规模全基因组关联研究(GWAS)的必要性。
Chin Clin Oncol. 2019-8
Chin Clin Oncol. 2016-10
Cancer Epidemiol. 2020-2-10
Chin Clin Oncol. 2019-8
CA Cancer J Clin. 2001
World J Gastroenterol. 2017-6-14
Chin Clin Oncol. 2019-8
Medicine (Baltimore). 2025-7-18
World J Gastrointest Surg. 2025-5-27
World J Gastrointest Oncol. 2025-5-15
Mol Biol Rep. 2025-5-29